Decoding the role of CYP450 enzymes in metabolism and disease: A comprehensive review

BH Abdelmonem, NM Abdelaal, EKE Anwer… - …, 2024 - pmc.ncbi.nlm.nih.gov
Cytochrome P450 (CYP450) is a group of enzymes that play an essential role in Phase I
metabolism, with 57 functional genes classified into 18 families in the human genome, of …

Pharmacogenomics in Asians: differences and similarities with other human populations

M Biswas, P **da, C Sukasem - Expert Opinion on Drug …, 2023 - Taylor & Francis
ABSTRACT Introduction Various pharmacogenomic (PGx) variants differ widely in different
ethnicities. and clinical outcomes associated with these variants may also be substantially …

Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies

M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - frontiersin.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes

CK Cho, E Ko, JY Mo, P Kang, CG Jang, SY Lee… - Archives of Pharmacal …, 2024 - Springer
Pantoprazole is used to treat gastroesophageal reflux disease (GERD), maintain healing of
erosive esophagitis (EE), and control symptoms related to Zollinger–Ellison syndrome …

Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing …

M Biswas, C Sukasem, MS Khatun Kali… - …, 2022 - Taylor & Francis
The aggregated risk of major adverse cardiovascular events (MACE) in acute coronary
syndrome (ACS) patients inheriting CYP2C19 loss-of function (LoF) alleles who underwent …

[HTML][HTML] Omeprazole therapy and CYP2C19 genotype

L Dean, M Kane - 2021 - europepmc.org
Omeprazole (brand name Prilosec) is a first-generation proton pump inhibitor (PPI) used to
treat gastroesophageal reflux disease (GERD), gastric ulcers, duodenal ulcers, upper …

Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation

JH Kim, SJ Hong, JJ Cha, S Lim, HJ Joo, JH Park… - BMC medicine, 2024 - Springer
Background Concomitant use of clopidogrel and proton pump inhibitor (PPI) is common, but
PPI may reduce the antiplatelet effects of clopidogrel in patients undergoing percutaneous …

Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles …

M Biswas, S Rahaman, TK Biswas… - International journal of …, 2021 - Springer
Background Efficacy of clopidogrel may be diminished due to either co-administration of
proton pump inhibitors or carrying CYP2C19 loss-of-function alleles. However, patients may …

Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine

M Biswas, J Shobana, P **da… - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction Azole antifungal drugs are commonly prescribed to treat invasive fungal
infections in various disease conditions. However, these drugs are substrates and inhibitors …

[HTML][HTML] Clozapine therapy and CYP genotype

L Dean, M Kane - 2021 - europepmc.org
Clozapine is one of the most effective antipsychotics available in the treatment of
schizophrenia and the only antipsychotic found to be effective in treatment-resistant …